Find public sector tenders

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension Offer reference number: CM/MSR/17/5557 Period of framework agreement: 1 June 2024 to 31 May 2026 with option(s) to extend for up to a total period of 24 months.

To ensure specialist clinical focus, the audit is required to recruit a Clinical Lead from the field of Pulmonary Hypertension.

NHS National Framework Agreement Home Delivery Service Pulmonary HypertensionOffer reference number: CM/MSR/17/5539Period of framework agreement: 1 June 2020 to 31 May 2022 with option(s) to extend for up to a total period of 24 months.

Bayer PLC Iloprost Vetafee for treatment of pulmonary hypertension.

NHS National Framework Agreement — Home Delivery Service — Pulmonary Hypertension. The framework agreement is intended for use by NHS Trusts who are prescribing for Pulmonary Hypertension in England. The delivery location will usually be the pati ....

NHS National Framework Agreement — Home Delivery Service — Pulmonary Hypertension. The framework agreement is intended for use by NHS Trusts who are prescribing for Pulmonary Hypertension in England. The delivery location will usually be the pati ....

NHS National Framework Agreement Home Delivery Service Pulmonary Hypertension Offer reference number: CM/MSR/17/5539 Period of framework agreement: 1 June 2020 to 31 May 2022 with option(s) to extend for up to a total period of 24 months.

NHS national framework agreement home delivery service pulmonary hypertension.Offer reference number: CM/MSR/17/5539Period of framework agreement: 1.6.2020 to 31.5.2022 with option(s) to extend for up to a total period of 24 months.

NHS National framework for home delivery service of pulomary hypertension drugs

NHS National framework agreement for the Homcare delivery service of licensed products for use in England and Wales for the treatment of bleeding disorders including recombinants and plasma derived products.